• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人肝“干细胞”恶性肿瘤:4例

Hepatic 'stem cell' malignancies in adults: four cases.

作者信息

Theise N D, Yao J L, Harada K, Hytiroglou P, Portmann B, Thung S N, Tsui W, Ohta H, Nakanuma Y

机构信息

Department of Pathology, New York University Medical Center, New York, NY, USA.

出版信息

Histopathology. 2003 Sep;43(3):263-71. doi: 10.1046/j.1365-2559.2003.01707.x.

DOI:10.1046/j.1365-2559.2003.01707.x
PMID:12940779
Abstract

AIMS

Combined hepatocellular/cholangiocarcinomas have been explained by some investigators as bidirectional differentiation of neoplastic progenitor cell populations. The presence of hepatic progenitor cells has now been confirmed in humans, though whether they can give rise to malignant tumours has not been confirmed. We report four cases of small tumours identified in livers with features of chronic hepatitis which may suggest a role for malignant transformation of hepatic stem cells in hepatic malignancies.

METHODS

Tumour samples were studied from four patients by histochemistry and immunohistochemistry.

RESULTS

Two patients had chronic hepatitis B, one had chronic hepatitis C and chronic alcoholic liver injury, and one had non-B non-C chronic hepatitis. Stages of disease ranged from portal fibrosis to cirrhosis. All tumours contained undifferentiated cells with morphological and immunohistochemical features that would be expected of hepatic progenitor cells. These cells merged with both hepatocellular carcinoma and cholangiocarcinoma components as well as with mature appearing hepatocytes within the tumours.

CONCLUSION

We suggest that these tumours are of hepatic progenitor cell origin, supporting the concepts that human hepatocarcinogenesis can be based on transformation of progenitor cells and that such a process may underlie development of some mixed hepatocellular/cholangiocarcinomas and dysplastic nodules.

摘要

目的

一些研究者认为,肝细胞癌/胆管癌混合性肿瘤是肿瘤祖细胞群双向分化的结果。目前,人类肝脏中已证实存在肝祖细胞,但其是否会引发恶性肿瘤尚未得到证实。我们报告了4例在具有慢性肝炎特征的肝脏中发现的小肿瘤,这些肿瘤可能提示肝干细胞恶性转化在肝脏恶性肿瘤中的作用。

方法

对4例患者的肿瘤样本进行组织化学和免疫组织化学研究。

结果

2例患者患有慢性乙型肝炎,1例患有慢性丙型肝炎和慢性酒精性肝损伤,1例患有非乙非丙型慢性肝炎。疾病阶段从门脉纤维化到肝硬化不等。所有肿瘤均含有未分化细胞,其形态和免疫组织化学特征符合肝祖细胞的预期。这些细胞与肝细胞癌和胆管癌成分以及肿瘤内成熟的肝细胞融合。

结论

我们认为这些肿瘤起源于肝祖细胞,这支持了人类肝癌发生可能基于祖细胞转化的观点,并且这一过程可能是一些肝细胞癌/胆管癌混合性肿瘤和发育异常结节发生的基础。

相似文献

1
Hepatic 'stem cell' malignancies in adults: four cases.成人肝“干细胞”恶性肿瘤:4例
Histopathology. 2003 Sep;43(3):263-71. doi: 10.1046/j.1365-2559.2003.01707.x.
2
Bile ductular cell reaction with senescent hepatocytes in chronic viral hepatitis is lost during hepatocarcinogenesis.在慢性病毒性肝炎中,胆管细胞与衰老肝细胞的反应在肝癌发生过程中消失。
Pathol Int. 2009 Jul;59(7):471-8. doi: 10.1111/j.1440-1827.2009.02395.x.
3
Hepatic progenitor cells in human liver tumor development.人类肝脏肿瘤发生中的肝祖细胞
World J Gastroenterol. 2006 Oct 21;12(39):6261-5. doi: 10.3748/wjg.v12.i39.6261.
4
Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence.源自肝祖细胞的肝内胆管癌:免疫组织化学及双荧光免疫染色证据
Histopathology. 2008 Jan;52(2):224-32. doi: 10.1111/j.1365-2559.2007.02929.x.
5
[Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases].[具有干细胞特征的肝细胞-胆管细胞癌(胆管细胞样型):26例临床病理分析]
Zhonghua Bing Li Xue Za Zhi. 2016 Mar;45(3):175-9. doi: 10.3760/cma.j.issn.0529-5807.2016.03.007.
6
A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.肝细胞癌与胆管癌合并的组织病理学研究:胆管癌成分起源于肝细胞癌。
Hepatogastroenterology. 2007 Mar;54(74):508-13.
7
Loss of Dicer1 impairs hepatocyte survival and leads to chronic inflammation and progenitor cell activation.Dicer1的缺失会损害肝细胞存活,并导致慢性炎症和祖细胞活化。
World J Gastroenterol. 2015 Jun 7;21(21):6591-603. doi: 10.3748/wjg.v21.i21.6591.
8
Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma.探究肝祖细胞相关特征:乙型肝炎相关肝细胞-胆管细胞癌的组织学异质性。
J Huazhong Univ Sci Technolog Med Sci. 2017 Dec;37(6):873-879. doi: 10.1007/s11596-017-1820-y. Epub 2017 Dec 21.
9
Identification of hepatic stem/progenitor cells in canine hepatocellular and cholangiocellular carcinoma.鉴定犬肝细胞癌和胆管细胞癌中的肝干细胞/祖细胞。
Vet Comp Oncol. 2010 Jun;8(2):112-21. doi: 10.1111/j.1476-5829.2010.00210.x.
10
Expression of deleted in malignant brain tumours 1 (DMBT1) relates to the proliferation and malignant transformation of hepatic progenitor cells in hepatitis B virus-related liver diseases.缺失恶性脑瘤 1(DMBT1)的表达与乙型肝炎病毒相关肝病中肝祖细胞的增殖和恶性转化有关。
Histopathology. 2012 Jan;60(2):249-60. doi: 10.1111/j.1365-2559.2011.04082.x.

引用本文的文献

1
Liver transplantation for combined hepatocellular cholangiocarcinoma: Current evidence, selection criteria, and therapeutic controversies.肝细胞胆管癌联合肝移植:当前证据、选择标准及治疗争议
World J Gastrointest Surg. 2025 May 27;17(5):105783. doi: 10.4240/wjgs.v17.i5.105783.
2
Combined hepatocellular cholangiocarcinoma: A clinicopathological update.肝细胞胆管癌合并症:临床病理进展
World J Hepatol. 2024 May 27;16(5):766-775. doi: 10.4254/wjh.v16.i5.766.
3
Advances in Histological and Molecular Classification of Hepatocellular Carcinoma.
肝细胞癌组织学和分子分类的进展
Biomedicines. 2023 Sep 20;11(9):2582. doi: 10.3390/biomedicines11092582.
4
Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update.肝细胞癌-胆管癌合并症的病理学:最新进展
Cancers (Basel). 2023 Jan 13;15(2):494. doi: 10.3390/cancers15020494.
5
Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach.肝细胞-胆管细胞癌:病理学与诊断方法的最新进展
Biomedicines. 2022 Jul 29;10(8):1826. doi: 10.3390/biomedicines10081826.
6
Postresection prognosis of combined hepatocellular carcinoma-cholangiocarcinoma according to the 2010 World Health Organization classification: single-center experience of 168 patients.根据2010年世界卫生组织分类标准的肝细胞癌-胆管癌联合切除术后预后:168例患者的单中心经验
Ann Surg Treat Res. 2021 May;100(5):260-269. doi: 10.4174/astr.2021.100.5.260. Epub 2021 Apr 29.
7
Combined Hepatocellular-Cholangiocarcinoma: Changes in the 2019 World Health Organization Histological Classification System and Potential Impact on Imaging-Based Diagnosis.混合型肝细胞癌-胆管细胞癌:2019 年世界卫生组织组织学分类系统的变化及其对基于影像的诊断的潜在影响。
Korean J Radiol. 2020 Oct;21(10):1115-1125. doi: 10.3348/kjr.2020.0091. Epub 2020 Jul 27.
8
A case of small hepatocellular carcinoma with malignant ductular reaction.一例伴有恶性小胆管反应的小肝细胞癌
Int J Clin Exp Pathol. 2020 May 1;13(5):1073-1080. eCollection 2020.
9
Murine hepatoblast-derived liver tumors resembling human combined hepatocellular-cholangiocarcinoma with stem cell features.源自小鼠肝母细胞的肝肿瘤,类似于具有干细胞特征的人类肝细胞-胆管细胞癌。
Cell Biosci. 2020 Mar 13;10:38. doi: 10.1186/s13578-020-00395-2. eCollection 2020.
10
Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link.丝裂原活化蛋白激酶(MAPK)与胆管癌:缺失的一环。
Cells. 2019 Sep 28;8(10):1172. doi: 10.3390/cells8101172.